Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation

Journal of Proteomics

Volumn 110, Issue , 2014, Pages 155-171

  Chen, Sun Xia ^a   Xu, Xiao En ^a   Wang, Xiao Qing ^a   Cui, Shu Jian ^b   Xu, Lei Lei ^a   Jiang, Ying Hua ^a   Zhang, Yang ^a   Yan, Hai Bo ^a   Zhang, Qian ^a   Qiao, Jie ^a   Yang, Peng Yuan ^a   Liu, Feng ^a  

^a FUDAN UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

Cancer associated fibroblast; Colorectal cancer; Follistatin related protein 1; Proteomics; Secretome; Tumor microenvironment

Indexed keywords

CELL MEMBRANE PROTEIN; DECORIN; FOLLISTATIN RELATED PROTEIN; FOLLISTATIN RELATED PROTEIN 1; OSTEONECTIN; PEPTIDASE INHIBITOR; PROTEINASE INHIBITOR; SECRETORY PROTEIN; TRANSGELIN; UNCLASSIFIED DRUG; PROTEOME; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER INHIBITION; CANCER PROGNOSIS; CANCER TISSUE; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CLINICAL FEATURE; COCULTURE; COLORECTAL CARCINOMA; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; CHEMISTRY; COLON; COLORECTAL TUMOR; METABOLISM; METABOLOME; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL CULTURE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; FIBROBLASTS; METABOLOME; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOME; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84907542792     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.07.031     Document Type: Article

References (71)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. World Health Organization - International Agency for Research on Cancer http://www.iarc.fr/en/cancertopics/colorectaltopics.php.
4. Tripathi M., Billet S., Bhowmick N.A. Understanding the role of stromal fibroblasts in cancer progression. Cell Adh Migr 2012, 6:231-235.
5. Francia G., Emmenegger U., Kerbel R.S. Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy. Cancer Cell 2009, 15:3-5.
6. Hale M.D., Hayden J.D., Grabsch H.I. Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. Cell Oncol 2013, 36:95-112.
7. Gerber D.E., Gupta P., Dellinger M.T., Toombs J.E., Peyton M., Duignan I., et al. Stromal platelet-derived growth factor receptor alpha (PDGFRalpha) provides a therapeutic target independent of tumor cell PDGFRalpha expression in lung cancer xenografts. Mol Cancer Ther 2012, 11:2473-2482.
8. Mueller L., Goumas F.A., Affeldt M., Sandtner S., Gehling U.M., Brilloff S., et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 2007, 171:1608-1618.
9. Lazard D., Sastre X., Frid M.G., Glukhova M.A., Thiery J.P., Koteliansky V.E. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A 1993, 90:999-1003.
10. Christiansen V.J., Jackson K.W., Lee K.N., Downs T.D., McKee P.A. Targeting inhibition of fibroblast activation protein-alpha and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Neoplasia 2013, 15:348-358.
11. Sadlonova A., Mukherjee S., Bowe D.B., Gault S.R., Dumas N.A., Van Tine B.A., et al. Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. Am J Pathol 2007, 170:1064-1076.
12. Grisendi G., Bussolari R., Veronesi E., Piccinno S., Burns J.S., De Santis G., et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res 2011, 1:787-805.
13. Murata T., Mizushima H., Chinen I., Moribe H., Yagi S., Hoffman R.M., et al. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res 2011, 71:6633-6642.
14. Lin Z.Y., Chuang Y.H., Chuang W.L. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells. Biomed Pharmacother 2012, 66:525-529.
15. Simmons J.G., Pucilowska J.B., Keku T.O., Lund P.K. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2002, 283:G809-G818.
16. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
17. Wang D., Zhu T., Zhang F.B., He C. Expression of ADAMTS12 in colorectal cancer-associated stroma prevents cancer development and is a good prognostic indicator of colorectal cancer. Dig Dis Sci 2011, 56:3281-3287.
18. De Boeck A., Hendrix A., Maynard D., Van Bockstal M., Daniels A., Pauwels P., et al. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics 2013, 13:379-388.
19. Torres S., Bartolome R.A., Mendes M., Barderas R., Fernandez-Acenero M.J., Pelaez-Garcia A., et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 2013, 19:6006-6019.
20. Chen A.L., Soman K.V., Rychahou P.G., Luxon B.A., Evers B.M. Proteomic analysis of colonic myofibroblasts and effect on colon cancer cell proliferation. Surgery 2005, 138:382-390.
21. Wang Z.H., Ding K.F., Yu J.K., Zhai X.H., Ruan S.Q., Wang S.W., et al. Proteomic analysis of primary colon cancer-associated fibroblasts using the SELDI-ProteinChip platform. J Zhejiang Univ Sci B 2012, 13:159-167.
22. Karagiannis G.S., Petraki C., Prassas I., Saraon P., Musrap N., Dimitromanolakis A., et al. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 2012, 3:267-285.
23. Barderas R., Mendes M., Torres S., Bartolome R.A., Lopez-Lucendo M., Villar-Vazquez R., et al. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion. Mol Cell Proteomics 2013, 12:1602-1620.
24. Shin Y.K., Yoo B.C., Hong Y.S., Chang H.J., Jung K.H., Jeong S.Y., et al. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis 2009, 30:2182-2192.
25. Chen S.X., Xu X.E., Wang X.Q., Cui S.J., Xu L.L., Jiang Y.H., et al. Data from a proteomic analysis of colonic fibroblasts secretomes. Data in Brief 2014, [in press]. 10.1016/j.dib.2014.08.003.
26. Chen X., Aledia A.S., Ghajar C.M., Griffith C.K., Putnam A.J., Hughes C.C., et al. Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A 2009, 15:1363-1371.
27. Shaner N.C., Campbell R.E., Steinbach P.A., Giepmans B.N., Palmer A.E., Tsien R.Y. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 2004, 22:1567-1572.
28. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
29. Cui S.J., Xu L.L., Zhang T., Xu M., Yao J., Fang C.Y., et al. Proteomic characterization of larval and adult developmental stages in Echinococcus granulosus reveals novel insight into host-parasite interactions. J Proteomics 2013, 84:158-175.
30. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
31. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
32. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
33. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012, 10:e1001450.
34. Wu C.C., Hsu C.W., Chen C.D., Yu C.J., Chang K.P., Tai D.I., et al. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 2010, 9:1100-1117.
35. Diehl H.C., Stuhler K., Klein-Scory S., Volmer M.W., Schoneck A., Bieling C., et al. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl 2007, 1:47-61.
36. de Wit M., Kant H., Piersma S.R., Pham T.V., Mongera S., van Berkel M.P., et al. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling. J Proteomics 2014, 99C:26-39.
37. Bernhard O.K., Greening D.W., Barnes T.W., Ji H., Simpson R.J. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma. Biochim Biophys Acta 1834, 2013:2372-2379.
38. Xue H., Lu B., Zhang J., Wu M., Huang Q., Wu Q., et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010, 9:545-555.
39. Choi D.S., Choi D.Y., Hong B.S., Jang S.C., Kim D.K., Lee J., et al. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracell Vesicles 2012, 1:18704.
40. Imperlini E., Colavita I., Caterino M., Mirabelli P., Pagnozzi D., Del Vecchio L., et al. The secretome signature of colon cancer cell lines. J Cell Biochem 2013, 114:2577-2587.
41. Ji H., Greening D.W., Kapp E.A., Moritz R.L., Simpson R.J. Secretome-based proteomics reveals sulindac-modulated proteins released from colon cancer cells. Proteomics Clin Appl 2009, 3:433-451.
42. Yu H., Konigshoff M., Jayachandran A., Handley D., Seeger W., Kaminski N., et al. Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J 2008, 22:1778-1789.
43. Tiedemann R.E., Zhu Y.X., Schmidt J., Shi C.X., Sereduk C., Yin H., et al. Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome. Cancer Res 2012, 72:757-768.
44. Xu X., Qiao M., Zhang Y., Jiang Y., Wei P., Yao J., et al. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer. Proteomics 2010, 10:1374-1390.
45. Rajakumara E., Wang Z., Ma H., Hu L., Chen H., Lin Y., et al. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol Cell 2011, 43:275-284.
46. Sadlonova A., Novak Z., Johnson M.R., Bowe D.B., Gault S.R., Page G.P., et al. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 2005, 7:R46-R59.
47. Kim S.H., Choe C., Shin Y.S., Jeon M.J., Choi S.J., Lee J., et al. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture. Anticancer Res 2013, 33:2001-2009.
48. Dong-Le Bourhis X., Berthois Y., Millot G., Degeorges A., Sylvi M., Martin P.M., et al. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997, 71:42-48.
49. Lebret S.C., Newgreen D.F., Thompson E.W., Ackland M.L. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res 2007, 9:R19.
50. Bi X., Pohl N.M., Qian Z., Yang G.R., Gou Y., Guzman G., et al. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 2012, 33:326-330.
51. Li Q., Shi R., Wang Y., Niu X. TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells. Tumour Biol 2013, 34:505-513.
52. Chan Q.K., Ngan H.Y., Ip P.P., Liu V.W., Xue W.C., Cheung A.N. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis. Carcinogenesis 2009, 30:114-121.
53. Su Y., Wagner E.R., Luo Q., Huang J., Chen L., He B.C., et al. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011, 30:3907-3917.
54. Xu X.L., Lee T.C., Offor N., Cheng C., Liu A., Fang Y., et al. Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5. Am J Pathol 2010, 177:424-435.
55. Bhoopathi P., Gorantla B., Sailaja G.S., Gondi C.S., Gujrati M., Klopfenstein J.D., et al. SPARC overexpression inhibits cell proliferation in neuroblastoma and is partly mediated by tumor suppressor protein PTEN and AKT. PLoS One 2012, 7:e36093.
56. Wang H.Y., Li Y.Y., Shao Q., Hou J.H., Wang F., Cai M.B., et al. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis. J Transl Med 2012, 10:27.
57. Kanno A., Satoh K., Masamune A., Hirota M., Kimura K., Umino J., et al. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer 2008, 122:2707-2718.
58. Ronca R., Alessi P., Coltrini D., Di Salle E., Giacomini A., Leali D., et al. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer. J Pathol 2013, 230:228-238.
59. Liu Y., Carson-Walter E.B., Cooper A., Winans B.N., Johnson M.D., Walter K.A. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol 2010, 99:13-24.
60. Fuyuhiro Y., Yashiro M., Noda S., Kashiwagi S., Matsuoka J., Doi Y., et al. Upregulation of cancer-associated myofibroblasts by TGF-beta from scirrhous gastric carcinoma cells. Br J Cancer 2011, 105:996-1001.
61. Henriksson M.L., Edin S., Dahlin A.M., Oldenborg P.A., Oberg A., Van Guelpen B., et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am J Pathol 2011, 178:1387-1394.
62. Johnson L.A., Sauder K.L., Rodansky E.S., Simpson R.U., Higgins P.D. CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts. Exp Mol Pathol 2012, 93:91-98.
63. Valentich J.D., Popov V., Saada J.I., Powell D.W. Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am J Physiol 1997, 272:C1513-C1524.
64. Hu C., Wang Z., Zhai L., Yang M., Shan L., Chai C., et al. Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells. Oncol Lett 2013, 5:609-612.
65. Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 2014, 25:735-747.
66. Ozdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014, 25:719-734.
67. Clutter S.D., Wilson D.C., Marinov A.D., Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol 2009, 182:234-239.
68. Reddy S.P., Britto R., Vinnakota K., Aparna H., Sreepathi H.K., Thota B., et al. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Clin Cancer Res 2008, 14:2978-2987.
69. Liu S., Wang L., Wang W., Lin J., Han J., Sun H., et al. TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. Exp Mol Pathol 2006, 80:132-140.
70. Ouchi N., Asaumi Y., Ohashi K., Higuchi A., Sono-Romanelli S., Oshima Y., et al. DIP2A functions as a FSTL1 receptor. J Biol Chem 2010, 285:7127-7134.
71. Chunhua L., Donglan L., Xiuqiong F., Lihua Z., Qin F., Yawei L., et al. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. J Nutr Biochem 2013, 24:1766-1775.